EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue: potential use for suppression of local recurrence of pancreatic cancer



New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue: potential use for suppression of local recurrence of pancreatic cancer



Journal of Biomedical Materials Research. Part B, Applied Biomaterials 73(1): 203-207



Local recurrence is a major cause of death of patients who have undergone resection for pancreatic cancer. To reduce the incidence of local recurrence, a new drug-infusion device, which is fixed on resected tissues immediately after surgery, was devised for trans-tissue, sustained local delivery. The drug-infusion device proposed here has the following functions: tight adhesion of the device on resected tissues, sustained drug infusion to the tissue, drug reloading, and easy removal from the body after use. The fabricated prototype experimental device, described here, was a thin infusion pouch made of a thin elastomer film (segmented polyurethane), which is connected to an elastomeric tube for drug reloading. The suppressive effect of the device delivering the anticancer agent, gemcitabine (GEM), was examined using subcutaneous tumor-bearing athymic mouse. A low-dose, local sustained GEM delivery using the device significantly suppressed the tumor growth and regrowth after surgery. The preliminary model experimental result appears to provide a promising therapeutic procedure for increased survival rate of the patients undergoing surgery for pancreatic cancer. (c) 2004 Wiley Periodicals, Inc.

(PDF emailed within 0-6 h: $19.90)

Accession: 012352599

Download citation: RISBibTeXText

PMID: 15627244

DOI: 10.1002/jbm.b.30186



Related references

Novel strategic therapeutic approaches for prevention of local recurrence of pancreatic cancer after resection: trans-tissue, sustained local drug-delivery systems. Journal of Controlled Release 100(3): 317-330, 2004

Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lung cancer and the role of diabetes in local recurrence. Journal of Clinical Oncology 26(15_suppl): 7572-7572, 2016

Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer. Cancer 116(10): 2390-2400, 2010

Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Annals of Oncology 13(9): 1404-1413, 2002

Surgically resected local recurrence after endoscopic submucosal dissection of esophageal cancer--a case report. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 36(12): 2448-2450, 2010

Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer. Lung Cancer 75(3): 381-390, 2012

Incidence and factors associated with local and distal recurrence in surgically-resected non-small cell lung cancer. International Journal of Radiation Oncology Biology Physics 69(3): S506, 2007

In situ-formed, tissue-adhesive co-gel composed of styrenated gelatin and styrenated antibody: potential use for local anti-cytokine antibody therapy on surgically resected tissues. Biomaterials 25(27): 5867-5873, 2004

A Potential Nanofiber Membrane Device for Filling Surgical Residual Cavity to Prevent Glioma Recurrence and Improve Local Neural Tissue Reconstruction. Plos One 11(8): E0161435-E0161435, 2016

Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence. International Journal of Radiation Oncology, Biology, Physics 15(1): 89-97, 1988

Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable prognosis. Strahlentherapie und Onkologie 190(5): 485-490, 2014

A case of local recurrence of rectal cancer responding to local intraarterial infusion therapy. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 26(9): 1355-1357, 1999

Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 Surgically-treated patients from the Scandinavian Sarcoma Group Register. European Journal of Cancer 36(6): 710-716, April, 2000

Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer. Pancreatic Disorders & Therapy 5(2): -, 2016